跳至主要内容
临床试验/NCT06429943
NCT06429943已完成不适用

Cerebrolysin in Patients Diagnosed With SAH - an Observational Cohort Study (PILOT)

Pomeranian Medical University Szczecin1 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2021年1月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
47
试验地点
1
主要终点
GOS Glasgow Outcome Scale

研究概览

简要总结

Subarachnoid haemorrhage often affects people in middle age and is associated with high mortality or neurological damage. In recent years, advances in surgical techniques have im-proved the mortality rate. However, there is still need for the research for the optimal possible final effect of treatment. In our study, we've decided to examine the effect of a multimodal approach including Cerebrolysin in the supportive treatment of patients. We've examined the supply of neuroprotective drugs and neuromonitoring.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age >18 years old, diagnosis of SAH, treatment in ICU conditions

排除标准

  • age <18 years, medical history of allergy to Cerebrolysin, acute renal failure, pregnancy, multi organ trauma, death within 48 hours after admission

结局指标

主要结局

GOS Glasgow Outcome Scale

时间窗: 1 month

Glasgow Outcome Scale - 5 points scale, characterizing the patients' deficits

次要结局

  • LOS Length of Stay(hospitalisation time)
  • mortality(1 month)

研究者

发起方
Pomeranian Medical University Szczecin
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验